Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 3100 of 3284 entries
View as:

A Retrospective Study of Cardiovascular Events Related to the Use of Glucose Lowering Drug Treatment in Primary Care

Phase: N/A Priority: Normal
NCT ID: NCT01121315 Org: User:
Start: 05/31/10 End: 08/31/11 Due: 08/31/12

Regional Observatory on Metabolic Syndrome- LAZIO

Phase: N/A Priority: Normal
NCT ID: NCT00689455 Org: User:
Start: 10/31/07 End: 12/31/08 Due: 12/31/09

AMPLIFY - D6571C00001 Duaklir USA Phase III Study

Phase: N/A Priority: Normal
NCT ID: NCT02796677 Org: User:
Start: 07/05/16 End: 06/08/17 Due: 06/08/18

Study to Evaluate Efficacy and Safety of Pulmicort Respules in Japanese Adult Asthmatic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00855959 Org: User:
Start: 02/28/09 End: 08/31/09 Due: 08/31/10

Schizophrenic Patients in Integrated Care

Phase: N/A Priority: Normal
NCT ID: NCT00681629 Org: User:
Start: 07/31/08 End: 11/30/08 Due: 11/30/09

Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT04493853 Org: User:
Start: 07/13/20 End: 03/29/27 Due: 03/29/28

Single Dose Study to Assess Efficacy, Safety and Tolerability of LAS100977 in Asthmatic Patients.

Phase: N/A Priority: Normal
NCT ID: NCT01425801 Org: User:
Start: 08/01/11 End: 02/01/12 Due: 02/01/13

TAURAS - T790 AURA ScreenFailure SOC Registry Study

Phase: N/A Priority: Normal
NCT ID: NCT02405247 Org: User:
Start: 06/30/15 End: 07/31/15 Due: 07/31/16

Immediate Release (IR) to Sustained Release (SR) Switching Study: Study of Switching From IR Seroquel to SR Seroquel in Outpatients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00206128 Org: User:
Start: 11/30/04 End: 02/28/06 Due: 02/28/07

Nexium Capsules Clinical Experience Investigation

Phase: N/A Priority: Normal
NCT ID: NCT01434485 Org: User:
Start: 09/30/11 End: 03/31/14 Due: 03/31/15

Atacand (Candesartan) Real Life Study

Phase: N/A Priority: Normal
NCT ID: NCT00620178 Org: User:
Start: 03/31/08 End: 02/28/09 Due: 02/28/10

Evaluation of the Efficacy of Rosuvastatin in Daily Practice in Untreated High Risk Patients (CHALLENGE)

Phase: N/A Priority: Normal
NCT ID: NCT00574782 Org: User:
Start: 09/30/03 End: - Due: -

Safety, Pharmacokinetics and Pharmacodynamics After Single and Multiple Dosing of AZD5423 in Japanese Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01338350 Org: User:
Start: 06/30/11 End: 12/31/11 Due: 12/31/12

Study in Healthy Subjects to Compare the Concentrations of the Omega-3 Fatty Acids EPA and DHA in Blood When Delivered as Three New Capsules in Relation to the Epanova® Capsule Under Fasting and Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT02359045 Org: User:
Start: 02/12/15 End: 07/27/15 Due: 07/27/16

A Study to Understand the Safety, Tolerability, and Activity of Drug in Body Over a Period of Time of AZD2693, in Subjects of Non-Childbearing Potential in Overweight But Otherwise Healthy Subjects, and Healthy Chinese and Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04142424 Org: User:
Start: 10/28/19 End: 11/12/21 Due: 11/12/22

A Study to Investigate How Common Pancreatic Exocrine Insufficiency (PEI) is in Patients With Type 2 Diabetes and Also to Investigate the Uptake of a Single Dose of EPANOVA® or OMACOR® in Patients With Different Degrees of PEI

Phase: N/A Priority: Normal
NCT ID: NCT02370537 Org: User:
Start: 03/31/15 End: 11/30/15 Due: 11/30/16

DIALOOG: Crestor in Patients With Diabetes Mellitus Type 2: Lowering of LDL-C Levels to New European Guidelines

Phase: N/A Priority: Normal
NCT ID: NCT00233649 Org: User:
Start: 05/31/04 End: - Due: -

Study of Intragastric pH Profile After 5 Days Pantoprazole 40 mg iv Followed by Oral Esomeprazole 40 mg po or Oral Pantoprazole 40 mg po

Phase: N/A Priority: Normal
NCT ID: NCT00206050 Org: User:
Start: 09/30/04 End: 12/31/04 Due: 12/31/05

A Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD7594 Administered Once Daily by Inhalation in Asthmatic Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03622112 Org: User:
Start: 01/02/19 End: 09/30/19 Due: 09/30/20

Evaluation of Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Background Combination of Metformin and Sulfonylurea

Phase: N/A Priority: Normal
NCT ID: NCT01392677 Org: User:
Start: 10/31/11 End: 08/31/13 Due: 08/31/14

A Two-week Study Assessing the Onset of Effect Questionnaire Administered Pre-dose Versus Post-dose in Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00449501 Org: User:
Start: 03/31/07 End: 11/30/07 Due: 11/30/08

LINE: Treatment Patterns in postmenopausaL Women With Hormone Receptor Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01561443 Org: User:
Start: 05/31/12 End: 01/31/15 Due: 01/31/16

OPtimal Type 2 dIabetes Management Including Benchmarking and Standard trEatment.

Phase: N/A Priority: Normal
NCT ID: NCT00681850 Org: User:
Start: 03/31/08 End: 01/31/10 Due: 01/31/11

Clinical Practice of AECOPD Management in China

Phase: N/A Priority: Normal
NCT ID: NCT02051166 Org: User:
Start: 02/28/14 End: 08/31/14 Due: 08/31/15

A Study of the Onset and Offset of Antiplatelet Effects Comparing Ticagrelor, Clopidogrel, and Placebo With Aspirin

Phase: N/A Priority: Normal
NCT ID: NCT00528411 Org: User:
Start: 10/31/07 End: 03/31/09 Due: 03/31/10